Stay updated with breaking news from Frazier Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Autolus Therapeutics (NASDAQ:AUTL – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Thursday, Zacks.com reports. The firm currently has a $3.00 target price on the stock. Zacks Investment Research‘s target price indicates a potential upside of 7.14% from the company’s current price. […]
Sierra Oncology (NASDAQ:SRRA – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. The brokerage currently has a $61.00 target price on the biotechnology company’s stock. Zacks Investment Research‘s price objective indicates a potential upside […]
Wall Street analysts predict that Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) will post earnings per share of ($0.25) for the current quarter, Zacks reports. Zero analysts have made estimates for Pardes Biosciences’ earnings. The highest EPS estimate is ($0.23) and the lowest is ($0.27). The company is expected to issue its next earnings report […]
KalVista Pharmaceuticals (NASDAQ:KALV – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “KalVista Pharmaceuticals, Inc. is a pharmaceuticals company. It engages in discovery, development and commercialization of small molecule protease inhibitors […]
Equities research analysts forecast that Silence Therapeutics plc (NASDAQ:SLN – Get Rating) will report ($0.62) earnings per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Silence Therapeutics’ earnings. The firm is scheduled to report its next quarterly earnings results on Monday, January 1st. On average, analysts expect that Silence […]